Yahoo
NYSE USD

Ecolab Inc. (ECL)

302.98 +2.12 (+0.70%)
At close: October 30 at 4:02:04 PM EDT
302.98 0.00 (0.00%)
After hours: October 30 at 5:00:26 PM EDT
Trade Ecolab on Coinbase
Chart Range Bar
Loading chart for ECL

What's happening with ECL?

41m ago
Powered by Yahoo Scout

Ecolab’s third-quarter results showed 7% organic sales growthand a 19.6% organic operating-income margin, supported by high-tech, life sciences, digital, and pest-management demand. However, CoolIT integration costs, higher borrowing, and elevated capital spending pressured near-term earnings. Management expects 2027 organic growth near the upper end of 5%–7%, with adjusted operating margins reaching 20%.

Powered by Yahoo Scout
  • Previous Close 300.86
  • Open 301.84
  • Bid 296.40 x 16000
  • Ask 307.05 x 28000
  • Day's Range 300.71 - 305.71
  • 52 Week Range 243.15 - 309.27
  • Volume 1,728,619
  • Avg. Volume 1,357,221
  • Market Cap (intraday) 84.976B
  • Beta (5Y Monthly) 0.88
  • PE Ratio (TTM) 41.22
  • EPS (TTM) 7.35
  • Earnings Date Oct 27, 2026
  • Forward Dividend & Yield 2.92 (0.96%)
  • 1y Target Est 330.57
  • Morningstar Rating Rating available with Stock Picks access

Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through four segments: Global Water, Global Institutional & Specialty, Global Pest Elimination, and Global Life Sciences. The Global Water segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, primary metals and mining, power generation, global refining, petrochemical, pulp and paper industries. The Global Institutional & Specialty segment provides cleaning and sanitizing products to the foodservice, healthcare, hospitality, lodging, government, education and retail industries. The Global Pest Elimination segment provides pest elimination services to detect, prevent, and eliminate pests comprising rodents and insects in full-service and quick-service restaurants, food and beverage processors, hotels, grocery operations, and other commercial segments, including education, life sciences, and healthcare. The Global Life Sciences segment provides cleaning and contamination control solutions to pharmaceutical and personal care manufacturers. It offers its products under the Ecolab, Kay, Purolite, and Bioquell brand names. The company sells its products through field sales and corporate account personnel, distributors, and dealers. Ecolab Inc. was founded in 1923 and is headquartered in Saint Paul, Minnesota.

www.ecolab.com

48,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ECL
16.35%
S&P 500 (^GSPC)
10.73%

1-Year Return

ECL
19.13%
S&P 500 (^GSPC)
11.11%

3-Year Return

ECL
96.35%
S&P 500 (^GSPC)
81.91%

5-Year Return

ECL
44.21%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 4.69B
Earnings 551.3M
Profit Margin 11.74%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
1B
2B
3B
4B
11.0%
11.5%
12.0%
12.5%
13.0%

Analyst Insights

View More

Analyst Price Targets

300.00
330.57 Average
302.98 Current
360.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/29/2026
Analyst Wells Fargo
Rating Action Maintains
Rating Equal-Weight
Price Action Raises
Price Target 295 -> 315

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    11.99%

  • Return on Assets (ttm)

    7.29%

  • Return on Equity (ttm)

    20.77%

  • Revenue (ttm)

    17.37B

  • Net Income Avi to Common (ttm)

    2.08B

  • Diluted EPS (ttm)

    7.35

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    722.3M

  • Total Debt/Equity (mrq)

    133.33%

  • Levered Free Cash Flow (ttm)

    1.44B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: